View:
United States securities and exchange commission logo
March 31, 2021
Carl Firth, Ph.D.
Chief Executive Officer
ASLAN Pharmaceuticals Ltd
83 Clemenceau Avenue #12-03 UE Square
Singapore 239920
Re: ASLAN
Pharmaceuticals Ltd
Registration
Statement on Form F-3
Filed March 26,
2021
File No. 333-254768
Dear Dr. Firth:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Chris
Edwards at 202-580-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: J. Patrick Loofbourrow